Logan Capital Management Inc Charles River Laboratories International, Inc. Transaction History

Logan Capital Management Inc

$2.25 Billion
Q3 2025

A detailed history of Logan Capital Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Logan Capital Management Inc holds 13,017 shares of CRL stock, worth $2.18 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,017

Previous 11,087 17.41%

Holding current value

$2.18 Million

Previous $1.68 Million 21.05%

% of portfolio

0.09%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$145.57 - $178.99 $280,950 - $345,450	1,930 Added 17.41%	13,017 $2.04 Million
Q2 2025 Aug 01, 2025	SELL	$99.75 - $151.89 $48,578 - $73,970	-487 Reduced 4.21%	11,087 $1.68 Million
Q1 2025 May 16, 2025	SELL	$150.52 - $190.14 $1.58 Million - $1.99 Million	-10,482 Reduced 47.52%	11,574 $1.74 Million
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $298,942 - $369,435	-1,674 Reduced 7.05%	22,056 $4.07 Million
Q3 2024 Dec 06, 2024	SELL	$187.96 - $245.29 $51,689 - $67,454	-275 Reduced 1.15%	23,730 $4.67 Million

Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $72,855 - $94,861	-353 Reduced 1.45%	24,005 $4.96 Million
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $651,467 - $875,249	3,201 Added 15.13%	24,358 $6.6 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $394,848 - $573,216	-2,400 Reduced 10.19%	21,157 $5 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $550,654 - $616,271	2,832 Added 13.66%	23,557 $4.62 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $457,070 - $523,102	-2,488 Reduced 10.72%	20,725 $4.36 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $170,590 - $231,068	889 Added 3.98%	23,213 $4.68 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $26,018 - $33,009	-132 Reduced 0.59%	22,324 $4.86 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $340,433 - $467,507	1,866 Added 9.06%	22,456 $4.42 Million
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $233,932 - $346,550	-1,146 Reduced 5.27%	20,590 $4.41 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $106,292 - $150,637	416 Added 1.95%	21,736 $6.17 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $179,906 - $229,724	512 Added 2.46%	21,320 $8.03 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $227,683 - $280,021	-611 Reduced 2.85%	20,808 $8.59 Million
Q2 2021 Aug 17, 2021	BUY	$294.17 - $371.65 $496,853 - $627,716	1,689 Added 8.56%	21,419 $7.92 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $366,515 - $439,636	1,468 Added 8.04%	19,730 $5.72 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $4.05 Million - $4.61 Million	18,262 New	18,262 $4.56 Million

Others Institutions Holding CRL

# of Institutions

643

Shares Held

51.6M

Call Options Held

194K

Put Options Held

174K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account

Logan Capital Management Inc Charles River Laboratories International, Inc. Transaction History